CYTOR drives prostate cancer progression via facilitating AR-V7 generation and its oncogenic signalling

Clin Transl Med. 2023 May;13(5):e1230. doi: 10.1002/ctm2.1230.

Authors

Jianpeng Yu¹, Tianyu Shen², Yang Li¹, Tangxi Hao¹, Long Yang³, Hanlin Li¹, Xuan-Mei Piao⁴, Zheng Zhang¹, Shimiao Zhu¹, Changyi Quan¹, Wun-Jae Kim⁴, Yang Zhao¹, Yuanjie Niu¹, Zhiqun Shang¹

Affiliations

¹ Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China.
² School of Medical, Nankai University, Tianjin, China.
³ Department of Urology, Tianjin Medical University General Hospital, Tianjin, China.
⁴ Department of Urology, College of Medicine, Chungbuk National University, Cheongju, Chungbuk, South Korea.

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Humans
Male
Prostate
Prostatic Neoplasms, Castration-Resistant*
Receptors, Androgen

Substances

Receptors, Androgen